Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Recent Health Care Deals, week ending 9.11.15
AcquirerTargetPrice Agilent Technologies Inc. Seahorse Bioscience$235 million Concordia Healthcare Corp.Amdipharm Mercury Limited$3.3 billion Eprirus Biopharmaceuticals, Inc. Bioceros Holding B.V.$14.1 million Biogen Inc. License to MT-1303$60 million Apricus Biosciences, Inc. U.S. rights to Vitaros™$1... Read More »Recent Health Care Deals, Week Ending Sept. 4, 2015
AcquirerTargetTarget SectorPrice LHC Group, Inc. Halcyon Hospice LLCHome Health & Hospice$58.5 million Allergan plcAqueSys, Inc. Medical Devices$300 million Cilpa Ltd. 2 U.S. generic drug companiesPharmaceuticals$550 million Care Capital Properties 9 senior care propertiesLong-Term Care$190... Read More »Biggest Health Care Deals in August 2015
August 2015 turned out to be busier than usual, for the last month of summer. We counted 124 health care transactions with a combined value of nearly $12 billion. Not bad for the dog days of summer. Five deals disclosed prices of $1 billion or more. Here they are. AcquirerTargetPrice Greatbatch, Inc. Lake Region Medical$1.73 billion Team Health HoldingsIPC Healthcare, Inc. $1.60 billion Mallinckrodt plcTherakos, Inc. $1.32 billion IBM Merge Healthcare$1.0 billion Valeant Pharmaceuticals InternationalSprout Pharmaceuticals$1.0 billion Source: The Health Care M&A Information Source, September 4,... Read More »Recent Health Care M&A Deals, Week Ending August 28, 2015
eHealth AcquirerTargetPrice Cardinal Health, Inc.NaviHealth$290 million Cardon OutreachDiversified Healthcare ResourcesMerger Medical Specialties Distributors,LLCVerbal Applications, Inc.... Read More »Recent Health Care M&A Deals, Week Ending August 18, 2015
TargetAcquirerPrice Pharmaceuticals R-Pharm US LLCIxempra®N/A AbbVie Inc.Rights to a Priority Review Voucher$350 million Valeant Pharmaceuticals InternationalSprout Pharmaceuticals, Inc.$1 billion Raptor Pharmaceuticals Corp.Quinsair™$68.4 million Novartis AGRemaining rights to ofatumumab$300... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
